SCHEMBL5374221

SCHEMBL5374221

C[C@H]1C[C@@H](Cc2ccccc2)CCN1c1cc2cc(C(N)=O)ccc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
GRIN2B Q13224 2/20 0.45
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2A Q12879 1/20 0.45
GRIN2C Q14957 1/20 0.45
GRIN3A Q8TCU5 1/20 0.45
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
ACHE P22303 1/20 0.41
CHEK1 O14757 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5374216 1.00 GAA (0.46) GAAMEN1KMT2AGRIN2BGRIN2D
SCHEMBL5732647 0.89 GAA (0.48) GAAMEN1KMT2AGRIN2BGRIN2D
SCHEMBL5203581 0.84 GAA (0.54) GAAMEN1KMT2AGRIN2BGRIN2D
SCHEMBL7076356 0.83 MMP2 (0.39) SLC6A2SLC6A4SLC6A3CHEK1OPRM1
SCHEMBL7076354 0.83 MMP2 (0.39) SLC6A2SLC6A4SLC6A3CHEK1OPRM1
SCHEMBL5733660 0.76 GAA (0.54) GAAMEN1KMT2AGRIN2BGRIN2D
SCHEMBL5374691 0.74 GAA (0.47) GAAMEN1KMT2AGRIN2BGRIN2D
SCHEMBL5374213 0.74 F2 (0.50) GAAACHEOPRM1OPRD1OPRK1
SCHEMBL5733310 0.74 GAA (0.44) GAAMEN1KMT2AGRIN2BGRIN2D
SCHEMBL5376256 0.73 GAA (0.42) GAAMEN1KMT2AGRIN2BGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189739-B2 Compounds and methods to treat cardiac failure and other disorders SCIOS, INC. (US) 2007-03-13 US disclosed
EP-1080078-B1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC (US) 2006-02-01 EP disclosed
US-6589954-B1 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful SCIOS, INC. 2003-07-08 US disclosed
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed